Document is current
Any future updates will be listed below
-
Authors
Aldhouse, Natalie V. J. http://orcid.org/0000-0001-6573-7431
Kitchen, Helen http://orcid.org/0000-0001-5519-0794
Knight, Sarah http://orcid.org/0000-0002-3586-6184
Macey, Jake http://orcid.org/0000-0003-2697-0438
Nunes, Fabio P. http://orcid.org/0000-0002-8833-2223
Dutronc, Yves http://orcid.org/0000-0002-1284-1152
Mesinkovska, Natasha http://orcid.org/0000-0002-2705-7002
Ko, Justin M. http://orcid.org/0000-0003-4232-5906
King, Brett A. http://orcid.org/0000-0002-4576-4616
Wyrwich, Kathleen W. http://orcid.org/0000-0002-8851-350X
-
Funding
Funding for this research was provided by:
Eli Lilly and Company (-)
- License Information
-
More Information
Article History
Received: 2 March 2020
Accepted: 18 August 2020
First Online: 11 September 2020
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Western Institutional Review Board [ref #20171820]) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: Natalie V. J. Aldhouse, Helen Kitchen, Sarah Knight, and Jake Macey are employees of DRG Abacus, a health economic and outcomes research consultancy that provides consultancy for pharmaceutical and biotech companies. Eli Lilly funded DRG Abacus to undertake this research. Fabio P. Nunes and Yves Dutronc are employees and stockholders at Eli Lilly and Company. Natasha Mesinkovska has no potential conflicts of interest. Dr. Justin M. Ko provides consultancy for Eli Lilly and Company. Dr. Brett A. King has served on advisory boards and is a consultant and clinical trial investigator for Concert Pharmaceuticals Inc., Eli Lilly and Company, and Pfizer Inc.; he is a consultant for Aclaris Therapeutics Inc. and Dermavant Sciences Inc. Kathleen W. Wyrwich was an employee at Eli Lilly and Company when this research was conducted, and is a stockholder at Eli Lilly and Company; she is now an employee and stockholder at Pfizer Inc.
